Viewing Study NCT04412668


Ignite Creation Date: 2025-12-24 @ 5:49 PM
Ignite Modification Date: 2025-12-29 @ 6:17 AM
Study NCT ID: NCT04412668
Status: COMPLETED
Last Update Posted: 2023-08-18
First Post: 2020-06-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Evaluate the Safety and Efficacy of ATYR1923 (Efzofitimod) In Participants With Severe Pneumonia Related to COVID-19
Sponsor: aTyr Pharma, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-06-04
Start Date Type: ACTUAL
Primary Completion Date: 2020-10-23
Primary Completion Date Type: ACTUAL
Completion Date: 2020-10-23
Completion Date Type: ACTUAL
First Submit Date: 2020-06-01
First Submit QC Date: None
Study First Post Date: 2020-06-02
Study First Post Date Type: ACTUAL
Results First Submit Date: 2023-06-27
Results First Submit QC Date: None
Results First Post Date: 2023-08-18
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-07-25
Last Update Post Date: 2023-08-18
Last Update Post Date Type: ACTUAL